Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic Melanoma.
Váraljai R, Wistuba-Hamprecht K, Seremet T, Diaz JMS, Nsengimana J, Sucker A, Griewank K, Placke JM, Horn PA, von Neuhoff N, Shannan B, Chauvistré H, Vogel FCE, Horn S, Becker JC, Newton-Bishop J, Stang A, Neyns B, Weide B, Schadendorf D, Roesch A. Váraljai R, et al. Among authors: seremet t. JCO Precis Oncol. 2019 Feb 15;3:PO.18.00229. doi: 10.1200/PO.18.00229. eCollection 2020. JCO Precis Oncol. 2019. PMID: 32914028 Free PMC article.
The predictive and prognostic significance of cell-free DNA concentration in melanoma.
Váraljai R, Elouali S, Lueong SS, Wistuba-Hamprecht K, Seremet T, Siveke JT, Becker JC, Sucker A, Paschen A, Horn PA, Neyns B, Weide B, Schadendorf D, Roesch A. Váraljai R, et al. Among authors: seremet t. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):387-395. doi: 10.1111/jdv.16766. Epub 2020 Jul 28. J Eur Acad Dermatol Venereol. 2021. PMID: 32569440
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Schreuer M, Meersseman G, Van Den Herrewegen S, Jansen Y, Chevolet I, Bott A, Wilgenhof S, Seremet T, Jacobs B, Buyl R, Maertens G, Neyns B. Schreuer M, et al. Among authors: seremet t. J Transl Med. 2016 Apr 19;14:95. doi: 10.1186/s12967-016-0852-6. J Transl Med. 2016. PMID: 27095081 Free PMC article.
64 results